Comments
With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 28th May, 2019 at 01:00 p.m. and concluded on 07:00 p.m. 1) Considered, adopted and approved Audited Financial Results for the quarter and year ended on 31st March, 2019. 2) Adoption of Secretarial Audit Report for Financial Year 2018-19 3) The Board accepted resignation of Mr. Karnik Shah from the post of CFO of the Company. 4) Appointment of Mr. Karnik Shah as a CEO of the Company. 5) Reviewed business of the Company
Pdf Link: Shukra Pharmaceuticals Ltd - Audited Results For The Year Ended 31/03/2019
Source : BSE - www.bseindia.com
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.